science public policy EN

science public policy EN

This paper brings forward why capital investors choose to invest in certain health technology-based ventures and not others, and how they influence the innovation process. Lehoux, P., Miller, F.A., Daudelin, G., Urbach, D.R. (2015). How venture capitalists decide which new medical technologies come to exist. Science & Public Policy. doi: 10.1093/scipol/scv051

This paper brings forward why capital investors choose to invest in certain health technology-based ventures and not others, and how they influence the innovation process.

Lehoux, P., Miller, F.A., Daudelin, G., Urbach, D.R. (2015). How venture capitalists decide which new medical technologies come to exist. Science & Public Policy. doi: 10.1093/scipol/scv051